BOS Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
BOS Asset Management's PFE Position: Q4 2025 in Review
BOS Asset Management sold out of Pfizer (PFE) in Q4 2025, closing a stake of 7,930 shares — an estimated $202K sold.
BOS Asset Management first reported a position in PFE in Q4 2022 and held it in 12 quarters. The position peaked at $488K in Q4 2022. 2,906 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- BOS Asset Management reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
- BOS Asset Management sold 7,930 Pfizer shares in Q4 2025, an estimated $202K.
- BOS Asset Management first reported a position in Pfizer in Q4 2022 and held it in 12 quarters.
- BOS Asset Management's Pfizer position peaked at $488K in Q4 2022.
- 2,906 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on BOS Asset Management's 13F filing for Q4 2025, filed 9 Jan 2026.